\s=b\Only two definite cases of quinidine-induced systemic lupus erythematosus (SLE) 
The disease did not return after steroids were withdrawn. The index case (case 1) demonstrated coagulation abnor¬ malities that can be caused by quinidine. These include thrombocytopenia, prolonged PT and PTT, and a factor IX (Christmas factor) deficiency. Thrombocytopenia occurs in about 3% of patients receiving quinidine and is thought to be due to antibodies to platelet-quinidine complexes. Quinidine is also known to cause hypoprothrombinemia and to potentiate the anticoagulant effects of warfarin sodium. 4, 6 We are unaware of any reports in the English-language literature of quinidine prolonging the PTT or causing a factor IX deficiency, although this is described in the nonEnglish literature. 9, 10 Each of the five patients in this article was withdrawn from quinidine therapy and treated with tapering doses of oral prednisone ( Only one patient in this series was tested for ANAs long after the syndrome had resolved. Iri this patient the ANA test remained positive six years later, but the patient was requiring antiarrhythmic therapy with phenytoin, which can induce ANA formation.1 The other four patients were not followed up long enough to determine if their ANAs would disappear, but three of these patients and one patient described in the literature2 had positive ANA tests more than a year after quinidine therapy was discontinued. Prospective studies are needed to determine the incidence of quinidine-induced ANA formation and a lupuslike syn¬ drome. Also, the type of ANA associated with quinidine is yet to be determined. Long-term follow-up would be helpful to determine if ANAs completely disappear in any of the patients described herein, and to assure that disease flares never occur long after the quinidine has been stopped.
Full case reports of patients 2 through 5 are available from the authors on request.
